TNF and psoriasis: As it is a T cell mediated disorder, clinical trials are underway with agents attempting to suppress the “inflammation characteristic” of psoriasis targetting TNF-alpha and other proinflammatory cytokines, T cell activation and lymphocyte trafficking.